It’s High-Risk Class I For Vyaire’s Recall Of Bellavista Ventilators
The US FDA on 17 February labeled a recall of 2,605 Bellavista 1000 and 1000e series ventilators as class I. Vyaire Medical Inc. had recalled the vents in late December.
You may also be interested in...
No patient injuries have been reported due to the problem, which is now the subject of a voluntary field correction.
In this FINAL EPISODE of Speaking Of Medtech: The US FDA got something it desperately wanted in its latest user-fee package with industry: a Total Product Lifecycle Advisory Program pilot, or TAP. The agency says TAP will allow for earlier and more frequent engagement with developers – but is it needed?
People with obesity now have new tools to help them lose weight, thanks to the US agency’s de novo authorization.